Fla. Stat. 408.0611
Electronic prescribing clearinghouse


(1)

It is the intent of the Legislature to promote the implementation of electronic prescribing by health care practitioners, health care facilities, and pharmacies in order to prevent prescription drug abuse, improve patient safety, and reduce unnecessary prescriptions. To that end, it is the intent of the Legislature to create a clearinghouse of information on electronic prescribing to convey the process and advantages of electronic prescribing; to provide information regarding the availability of electronic prescribing products, including no-cost or low-cost products; and to regularly convene stakeholders to assess and accelerate the implementation of electronic prescribing.

(2)

As used in this section, the term:“Electronic prescribing” means, at a minimum, the electronic review of the patient’s medication history, the electronic generation of the patient’s prescription, and the electronic transmission of the patient’s prescription to a pharmacy.“Health care practitioner” means an individual authorized by law to prescribe drugs.

(a)

“Electronic prescribing” means, at a minimum, the electronic review of the patient’s medication history, the electronic generation of the patient’s prescription, and the electronic transmission of the patient’s prescription to a pharmacy.

(b)

“Health care practitioner” means an individual authorized by law to prescribe drugs.

(3)

The agency shall work in collaboration with private sector electronic prescribing initiatives and relevant stakeholders to create a clearinghouse of information on electronic prescribing for health care practitioners, health care facilities, and pharmacies. These stakeholders shall include organizations that represent health care practitioners, organizations that represent health care facilities, organizations that represent pharmacies, organizations that operate electronic prescribing networks, organizations that create electronic prescribing products, and regional health information organizations. Specifically, the agency shall:Provide on its website:
Information regarding the process of electronic prescribing and the availability of electronic prescribing products, including no-cost or low-cost products;
Information regarding the advantages of electronic prescribing, including using medication history data to prevent drug interactions, prevent allergic reactions, and deter doctor and pharmacy shopping for controlled substances;
Links to federal and private sector websites that provide guidance on selecting an appropriate electronic prescribing product; and
Links to state, federal, and private sector incentive programs for the implementation of electronic prescribing.
Convene quarterly meetings of the stakeholders to assess and accelerate the implementation of electronic prescribing.

(a)

Provide on its website:Information regarding the process of electronic prescribing and the availability of electronic prescribing products, including no-cost or low-cost products;Information regarding the advantages of electronic prescribing, including using medication history data to prevent drug interactions, prevent allergic reactions, and deter doctor and pharmacy shopping for controlled substances;Links to federal and private sector websites that provide guidance on selecting an appropriate electronic prescribing product; andLinks to state, federal, and private sector incentive programs for the implementation of electronic prescribing.
1. Information regarding the process of electronic prescribing and the availability of electronic prescribing products, including no-cost or low-cost products;
2. Information regarding the advantages of electronic prescribing, including using medication history data to prevent drug interactions, prevent allergic reactions, and deter doctor and pharmacy shopping for controlled substances;
3. Links to federal and private sector websites that provide guidance on selecting an appropriate electronic prescribing product; and
4. Links to state, federal, and private sector incentive programs for the implementation of electronic prescribing.

(b)

Convene quarterly meetings of the stakeholders to assess and accelerate the implementation of electronic prescribing.

(4)

Pursuant to s. 408.061, the agency shall monitor the implementation of electronic prescribing by health care practitioners, health care facilities, and pharmacies. The agency shall annually publish a report on the progress of implementation of electronic prescribing on its Internet website. Information reported pursuant to this subsection shall include federal and private sector electronic prescribing initiatives and, to the extent that data is readily available from organizations that operate electronic prescribing networks, the number of health care practitioners using electronic prescribing and the number of prescriptions electronically transmitted.

Source: Section 408.0611 — Electronic prescribing clearinghouse, https://www.­flsenate.­gov/Laws/Statutes/2024/0408.­0611 (accessed Aug. 7, 2025).

408.05
Florida Center for Health Information and Transparency
408.07
Definitions
408.08
Inspections and audits
408.09
Assistance on cost containment strategies
408.10
Consumer complaints
408.15
Powers of the agency
408.16
Health Care Trust Fund
408.18
Health Care Community Antitrust Guidance Act
408.20
Assessments
408.031
Short title
408.032
Definitions relating to Health Facility and Services Development Act
408.033
Local and state health planning
408.034
Duties and responsibilities of agency
408.035
Review criteria
408.036
Projects subject to review
408.037
Application content
408.038
Fees
408.039
Review process
408.040
Conditions and monitoring
408.40
Public Counsel
408.041
Certificate of need required
408.042
Limitation on transfer
408.043
Special provisions
408.044
Injunction
408.045
Certificate of need
408.50
Prospective payment arrangements
408.051
Florida Electronic Health Records Exchange Act
408.061
Data collection
408.062
Research, analyses, studies, and reports
408.063
Dissemination of health care information
408.064
Direct care worker education and awareness
408.70
Health care
408.185
Information submitted for review of antitrust issues
408.301
Legislative findings
408.302
Interagency agreement
408.0455
Rules
408.0511
Exemption from antitrust laws for persons or entities required to submit, receive, or publish data under ch. 2016-234
408.0512
Electronic health records system adoption loan program
408.0611
Electronic prescribing clearinghouse
408.0621
Blood clot and pulmonary embolism policy workgroup
408.7057
Statewide provider and health plan claim dispute resolution program
408.7071
Standardized claim form

Current through Fall 2025

§ 408.0611. Elec. prescribing clearinghouse's source at flsenate​.gov